<?xml version="1.0" ?>
<document id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9">
  <chunk id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c0" text="Novel broad spectrum virucidal molecules against enveloped viruses">
    <entity charOffset="31-40" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c0.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
  </chunk>
  <chunk id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1" text="Viral infections are an important cause of death worldwide. Unfortunately, there is still a lack of antiviral drugs or vaccines for a large number of viruses, and this represents a remarkable challenge particularly for emerging and re-emerging viruses. For this reason, the identification of broad spectrum antiviral compounds provides a valuable opportunity for developing efficient antiviral therapies. Here we report on a class of rhodanine and thiobarbituric derivatives displaying a broad spectrum antiviral activity against seven different enveloped viruses including an HSV-2 acyclovir resistant strain with favorable selectivity indexes. Due to their selective action on enveloped viruses and to their lipid oxidation ability, we hypothesize a mechanism on the viral envelope that affects the fluidity of the lipid bilayer, thus compromising the efficiency of virus-cell fusion and preventing viral entry.">
    <entity charOffset="100-109" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e0" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="100-115" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e1" ontology_id="CHEBI_36044" text="antiviral drugs" type="chemical"/>
    <entity charOffset="110-115" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e2" ontology_id="CHEBI_23888" text="drugs" type="chemical"/>
    <entity charOffset="307-316" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e3" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="384-393" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e4" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="434-443" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e5" ontology_id="CHEBI_8830" text="rhodanine" type="chemical"/>
    <entity charOffset="503-512" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e6" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="583-592" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e7" ontology_id="CHEBI_2453" text="acyclovir" type="chemical"/>
    <entity charOffset="669-675" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e8" ontology_id="CHEBI_5133" text="action" type="chemical"/>
    <entity charOffset="710-715" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e9" ontology_id="CHEBI_18059" text="lipid" type="chemical"/>
    <entity charOffset="817-822" id="1090afa5b76644ce9e3be9d9d0e67ad651f846d9.c1.e10" ontology_id="CHEBI_18059" text="lipid" type="chemical"/>
  </chunk>
</document>
